Published in Am J Pathol on March 01, 1988
novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol (1998) 1.90
Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A (1993) 1.59
The role of IGF-1R in pediatric malignancies. Oncologist (2009) 1.27
Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am J Pathol (1989) 1.04
Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci U S A (1994) 0.99
Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line. Am J Pathol (1994) 0.83
Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am J Pathol (1993) 0.80
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res (2014) 0.77
IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood. Clin Mol Pathol (1995) 0.75
Actions of insulin-like growth factors. Annu Rev Physiol (1985) 3.80
Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (1987) 3.52
Growth factors and cancer. Cancer Res (1986) 3.48
The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem (1982) 2.62
Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature (1985) 2.29
Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. J Clin Invest (1980) 2.15
Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature (1985) 2.06
Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci U S A (1986) 1.94
Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem (1981) 1.90
Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res (1986) 1.58
Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor. J Clin Endocrinol Metab (1985) 1.49
Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc Natl Acad Sci U S A (1987) 1.47
A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides. Nature (1978) 1.43
The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J Clin Endocrinol Metab (1987) 1.17
The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells. J Biol Chem (1984) 1.13
Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology (1987) 1.11
Relation of kidney tissue somatomedin-C/insulin-like growth factor I to postnephrectomy renal growth in the rat. Endocrinology (1985) 1.09
Phosphorylation of insulin receptors solubilized from rat skeletal muscle. Diabetes (1984) 0.89
Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth. J Cell Physiol (1985) 0.82
Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics (1997) 6.44
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell (1994) 4.26
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
Two species of lysosomal organelles in cultured human fibroblasts. Cell (1979) 3.64
Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science (1993) 3.52
Transmission through the female line of a mechanism constraining human fetal growth. Int J Epidemiol (2008) 3.42
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Molecular biology of mammalian glucose transporters. Diabetes Care (1990) 3.33
Agency in health care. Examining patients' preferences for attributes of the doctor-patient relationship. J Health Econ (1998) 2.80
Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial. Lancet (1975) 2.72
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Leucine. A possible regulator of protein turnover in muscle. J Clin Invest (1975) 2.67
Holy water--a risk factor for hospital-acquired infection. J Hosp Infect (1996) 2.65
Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 2.59
Improving outcomes for young people with diabetes: use of new technology and a skills-based training approach is urgently needed. Diabet Med (2001) 2.35
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
National cancer registration: an appraisal. Community Med (1983) 2.29
The transport of lysosomal enzymes. J Supramol Struct (1977) 2.22
Retrospective review of care and outcomes in young adults with type 1 diabetes. BMJ (2003) 2.22
Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry (1992) 2.20
Automatic external defibrillators--time for a change? Br Dent J (2005) 2.18
Hospital outbreak of multi-resistant Acinetobacter anitratus: an airborne mode of spread? J Hosp Infect (1987) 2.17
Structure and function of mammalian facilitative sugar transporters. J Biol Chem (1993) 2.14
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol (2005) 2.04
The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect (2001) 2.03
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J (1995) 2.02
Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum (1982) 2.00
Effect of p15-associated protease from an avian RNA tumor virus on avian virus-specific polyprotein precursors. J Virol (1980) 1.94
Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet (1991) 1.87
Preventable in-hospital medical injury under the "no fault" system in New Zealand. Qual Saf Health Care (2003) 1.84
Private costs associated with abdominal aortic aneurysm screening: the importance of private travel and time costs. J Med Screen (1995) 1.80
Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature (1985) 1.77
The nature of the oscillatory behaviour in electrical activity from pancreatic beta-cell. Horm Metab Res Suppl (1980) 1.76
Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int (1984) 1.76
Immunohistochemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin's disease. J Exp Med (1974) 1.73
Head circumference charts updated. Arch Dis Child (1985) 1.69
In-vitro activity of ten antimicrobial agents against penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother (1992) 1.68
Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes (1996) 1.65
Adverse events regional feasibility study: methodological results. N Z Med J (2001) 1.61
Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat. The effect of fatty acids, glucose, and pyruvate respiration. J Biol Chem (1972) 1.61
Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem (1997) 1.60
Human intestinal glucose transporter expression and localization of GLUT5. Am J Physiol (1992) 1.60
Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A (1993) 1.59
Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls. Ann Rheum Dis (1969) 1.58
Genetic epidemiology study of idiopathic talipes equinovarus. Am J Med Genet (1998) 1.57
Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ Res (1991) 1.51
Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization. J Biol Chem (1992) 1.50
Intratumoral fat in a renal oncocytoma mimicking angiomyolipoma. AJR Am J Roentgenol (1990) 1.49
The sizes and characteristics of the minority ethnic populations of Great Britain--latest estimates. Popul Trends (2001) 1.48
Adverse events regional feasibility study: indicative findings. N Z Med J (2001) 1.43
Swarming of Proteus--a solution to an old problem? Nature (1966) 1.41
Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol (1996) 1.41
Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition. Pigment Cell Melanoma Res (2012) 1.41
Human kidney alpha-L-iduronidase: purification and characterization. Arch Biochem Biophys (1978) 1.39
A New Zealand code of ethics. N Z Med J (1991) 1.39
Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci U S A (2001) 1.38
Eliminating selective stimulus control: a comparison of two procedures for teaching mentally retarded children to respond to compound stimuli. J Exp Child Psychol (1985) 1.38
In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation. J Immunother (2001) 1.38
Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol (1993) 1.38
Longitudinal study of Campylobacter jejuni bacteriophages and their hosts from broiler chickens. Appl Environ Microbiol (2004) 1.37
Transmission through the female line of a mechanism constraining human fetal growth. Ann Hum Biol (1986) 1.36
The prevalence of dementia, depression and neurosis in later life: the Liverpool MRC-ALPHA Study. Int J Epidemiol (1993) 1.34
A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells. EMBO J (1983) 1.33
Segregation analysis of idiopathic talipes equinovarus in a Texan population. Am J Med Genet (1998) 1.32
High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Biotechnology (N Y) (1991) 1.32
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer (1982) 1.32
Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes (1995) 1.29
Mechanotherapy: how physical therapists' prescription of exercise promotes tissue repair. Br J Sports Med (2009) 1.29
Measuring progress towards a primary care-led NHS. Br J Gen Pract (1999) 1.28
Growth in the first four years: I. The relative effects of gender and weight for gestational age at birth. Early Hum Dev (1982) 1.27
High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes (2000) 1.27
A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci (1985) 1.26
Calpains play a role in insulin secretion and action. Diabetes (2001) 1.25
WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science (1993) 1.25
Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett (1996) 1.23
Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem (1994) 1.23
Prevalence of dementia and depression among elderly people in black and ethnic minorities. Br J Psychiatry (1997) 1.22
Consultants in nhs scotland: a survey of work commitments, remuneration, job satisfaction and retirement plans. Scott Med J (2004) 1.22
Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem (2001) 1.22
The isolation of avian viral RNA and polypeptides. J Biol Chem (1979) 1.21
The effect of epinephrine, glucagon, and the nutritional state on the oxidation of branched chain amino acids and pyruvate by isolated hearts and diaphragms of the rat. J Biol Chem (1973) 1.21
Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nat Genet (1993) 1.20
The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol (1986) 1.18
Use of geographic and genotyping tools to characterise tuberculosis transmission in Montreal. Int J Tuberc Lung Dis (2007) 1.18
The relative contributions of different maternal factors in small-for-gestational-age pregnancies. Eur J Obstet Gynecol Reprod Biol (1981) 1.17
Job satisfaction, work-related stress and intentions to quit of Scottish GPS. Scott Med J (2002) 1.17
Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend (2005) 1.16
The "supply hypothesis" and medical practice variation in primary care: testing economic and clinical models of inter-practitioner variation. Soc Sci Med (2000) 1.16
Alternative splicing of sur2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J Biol Chem (1999) 1.15
Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res (1997) 1.13
Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma. Toxicol Lett (1997) 1.13